Theravance Biopharma Inc Sustainability Reports
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines. Its portfolio includes respiratory therapeutics such as YUPELRI (revefenacin) inhalation solution.
Sector: Manufacturing
Country: Cayman Islands
Exchange: Nasdaq
ISIN: KYG8807B1068
7 reports from 2014 to 2022